Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review

HIGHLIGHTS

  • who: Girma Tekle Gebremariam from the Institute (JBI) checklistCost-effectiveness data were rigorously summarized and synthesized narratively. Costs were School of Pharmacy, Addis Ababa University, Zambia Street, : have published the Article: Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review, in the Journal: (JOURNAL)
  • what: Literature search strategy This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) , and the review protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO, ID=CRD42020220276 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?